Atorvastatin can inhibit ovarian cancer by decreasing VEGF, TGF-β1 and increasing cytochrome-c and caspase-3 expressions

• मुख्य लेखकों: HongJu Chen (लेखक), HuaiJing Shi (लेखक), XinYan Jiang (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Polskie Towarzystwo Farmaceutyczne, 2024-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Objective: Atorvastatin (ATV), being widely utilized in clinical practice, is recognized as a prevalent cancer drug with established safety profiles. The objective of this study was to examine the potential anti-tumor effects of ATV in ovarian cancer (OC), as well as explore its underlying mechanism...